Magnetic resonance imaging (MRI) contrast agents are categorised according to the
following specific features: chemical composition including the presence or absence of …

In an era of personalized medicine, the clinical community has become increasingly focused
on understanding diseases at the cellular and molecular levels. Magnetic resonance …

The development of nuclear magnetic resonance (NMR) imaging techniques as a clinical
diagnostic modality has prompted the need for a new class of pharmaceuticals. These drugs …

Rationale and Objectives: To characterize and compare commercially available contrast
media (CM) for magnetic resonance imaging (MRI) in terms of their relaxivity at magnetic …

PURPOSE: To assess the utility of magnetic resonance (MR) cerebral blood volume (CBV)
maps in the evaluation of gliomas. MATERIALS AND METHODS: CBV maps from 19 …

This review focuses on MRI contrast agents that are responsive to a change in a
physiological biomarker. The response mechanisms are dependent on six physicochemical …

Gadolinium-labeled diethylenetriaminepentaacetic acid was used as a contrast agent for
stereotactic magnetic resonance (MR) imaging in six selected patients with brain tumors …

This review summarizes some of the developments of metal complexes and metal-complex-
bioconjugates for the diagnosis of disease states that have occurred over the past 10 years …

Because monoclonal antibodies can recognize and bind to specific groups of atoms such as
tumour antigens, they have promise for use in vivo as carriers of radionuclides, drugs or …

For more accurate diagnosis and effective treatment of cancer, we proposed to develop a
hetero-multinuclear metal complex based on the property of apoferritin (AFt) for targeting …